Onesource Specialty Pharma

Onesource Specialty Pharma Interest Expense

The Interest Expense of Onesource Specialty Pharma (ONESOURCE.NS) as of Oct 21, 2026 is -1.38 B INR. In the previous year, Interest Expense was -798.87 M INR — a change of 72.93% (lower).

Interest Expense

-1.38 BINR

YoY

72.93%

Last updated:

Interest Expense of Onesource Specialty Pharma is 2025 -1.38 B INR. Interest Expense of Onesource Specialty Pharma was 2024 -798.87 M INR. It decreases by 72.93% lower compared to the previous year.

The Onesource Specialty Pharma Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2023
-455.14 M INR
Jan 1, 2024
-798.87 M INR
Jan 1, 2025
-1.38 B INR
The Onesource Specialty Pharma Interest Expense history
YEARInterest ExpenseYoY
-1.38 BINR+72.93%
-798.87 MINR+75.52%
-455.14 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Onesource Specialty Pharma Stock analysis

What does Onesource Specialty Pharma do? Onesource Specialty Pharma Ltd operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO) within the Life Sciences Tools & Services industry. Based in Bangalore, Karnataka, the India-based company provides vertically integrated biopharma services, focusing on the development and manufacture of complex biologics, biosimilars, and vaccines. Its core offerings include prefilled syringes with or without safety devices, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors. The firm supports the development of complex biologics such as microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and ribonucleic acid (RNA) products. The company generates revenue by catering to a variety of capsule shapes and sizes through its integrated services. These services encompass formulations ranging from traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and su. By providing comprehensive biologics solutions, the firm serves clients requiring advanced manufacturing capabilities for diverse pharmaceutical delivery systems and therapeutic modalities. Onesource Specialty Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Onesource Specialty Pharma stock

Interest Expense of Onesource Specialty Pharma is -1.38 B INR in 2025.

Interest Expense of Onesource Specialty Pharma changed from -798.87 M INR to -1.38 B INR, representing a 72.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Onesource Specialty Pharma since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Onesource Specialty Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Onesource Specialty Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Onesource Specialty Pharma